TESARO INC's ticker is TSRO and the CUSIP is 881569107. A total of 279 filers reported holding TESARO INC in Q3 2017. The put-call ratio across all filers is 1.16 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2018 | $15,960,000 | +19.8% | 358,900 | +247.8% | 0.06% | +6.7% |
| Q3 2017 | $13,323,000 | -45.6% | 103,200 | -41.0% | 0.06% | -56.5% |
| Q2 2017 | $24,476,000 | -82.2% | 175,000 | -80.5% | 0.14% | -82.0% |
| Q1 2017 | $137,852,000 | +3362.7% | 895,900 | +2926.7% | 0.77% | +2642.9% |
| Q4 2016 | $3,981,000 | -77.3% | 29,600 | -83.1% | 0.03% | -77.2% |
| Q3 2016 | $17,562,000 | -70.5% | 175,200 | -87.0% | 0.12% | -73.1% |
| Q1 2016 | $59,519,000 | +17.6% | 1,351,785 | +39.7% | 0.46% | +9.3% |
| Q4 2015 | $50,632,000 | +13.6% | 967,728 | -13.0% | 0.42% | +19.4% |
| Q3 2015 | $44,579,000 | -18.9% | 1,111,700 | +19.0% | 0.35% | -8.1% |
| Q2 2015 | $54,939,000 | +17.5% | 934,500 | +14.7% | 0.38% | +19.4% |
| Q1 2015 | $46,775,000 | +104.0% | 814,900 | +32.2% | 0.32% | +98.1% |
| Q4 2014 | $22,924,000 | +389.4% | 616,409 | +254.2% | 0.16% | +360.0% |
| Q3 2014 | $4,684,000 | – | 174,008 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| INTERWEST VENTURE MANAGEMENT CO | 2,021,403 | $271,838,000 | 64.82% |
| NEA Management Company, LLC | 10,275,113 | $1,381,797,000 | 54.94% |
| ORACLE INVESTMENT MANAGEMENT INC | 1,248,086 | $167,843,000 | 27.84% |
| BLUE JAY CAPITAL MANAGEMENT, LLC | 89,695 | $12,062,000 | 7.28% |
| Perceptive Advisors | 687,993 | $92,521,000 | 6.58% |
| Avoro Capital Advisors LLC | 231,700 | $31,159,000 | 6.30% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 94,500 | $12,705,000 | 5.72% |
| Rock Springs Capital Management LP | 613,500 | $82,503,000 | 5.52% |
| SENZAR ASSET MANAGEMENT, LLC | 142,300 | $19,136,000 | 5.08% |
| BB BIOTECH AG | 974,582 | $131,062,000 | 4.85% |